Patents/Assignees

Askat Inc.

5 patents in portfolio

US12617776utility2026
Stable Salt and Crystal Forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1h-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol
0 cites
US12295962utility2025
Polymorphic Compounds and Uses Thereof
0 cites
US11964963utility2024
Stable Salt and Crystal Forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1h-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol
0 cites
US11840530utility2023
Selective EP4 Receptor Antagonistic Substance for Treatment of Cancer
0 cites
US11555023utility2023
Process for the Differential Solubility-driven Asymmetric Transformation of Substituted 2h-chromene-3-carboxylic Acids
0 cites